| Atorvastatin Impurity 28 |
2,2-二氯-1-(4-氟苯基)-2-苯基乙酮 |
1403667-07-1 |
| 2-Amino-7-(chloromethyl)pteridin-4(1H)-one |
叶酸杂质4 |
1391194-56-1 |
| 2-(1-methoxybutyl)-1-benzofuran |
胺碘酮-氨碘酮杂质 |
1391052-05-3 |
| Oxymetazoline hydrochloride EP impurity A |
Oxymetazoline hydrochloride EP impurity A |
1391194-44-7 |
| [2-[(1RS)-1-Methoxybutyl]benzofuran-3-yl][4-hydroxy-3,5-diiodophenyl]Methanone |
胺碘酮-氨碘酮杂质 |
1391054-75-3 |
| 1-cyclopropyl-2-(2-fluorophenyl)ethane-1,2-dione |
普拉格雷二酮 |
1391054-37-7 |
| 1-NaphthaleneethanaMine, 7-Methoxy-N-[2-(7-Methoxy-1-naphthalenyl)ethyl]- |
7-甲氧基-N-[2-(7-甲氧基-1-萘基)乙基]-1-萘乙胺 |
1385018-57-4 |
| Lansoprazole IMpurity H |
兰索拉唑杂质H |
1346598-28-4 |
| (S)-methyl 2-(2-chlorophenyl)-2-(2-(hydroxymethyl)-6,7- dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate |
氯吡格雷杂质29 |
1346231-35-3 |
| 13-Ethyl-3-ethynyl-18,19-dinor-17α-pregna-3,5-dien-20-yn-17-ol (Levo Norgestrel Impurity) |
左炔诺孕酮杂质C |
1337972-89-0 |
| 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-6,8-dioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide |
4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-6,8-dioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide |
1332391-92-0 |
| O-Desmethyl Mycophenolate Mofetil (Impurity A) |
霉酚酸酯杂质A |
1322681-36-6 |
| Atorvastatin Impurity 22 |
阿托伐他汀杂质22 |
1821498-27-4 |
| Emtricitabine Impurity 15 |
恩曲他滨杂质 15 |
1238210-22-4 |
| Difluprednate Impurity 14 |
二氟泼尼酯杂质 14 |
1234557-20-0 |
| WBYZCPYZHMZPHD-UHFFFAOYSA-N |
WBYZCPYZHMZPHD-UHFFFAOYSA-N |
1221160-70-8 |
| N-Desmethyl Zolmitriptan-d3 |
N-去甲基佐米曲普坦-d3 |
1217623-11-4 |
| (S)-5-((Tert-butylamino)methyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one |
利奈唑胺杂质11 |
1215006-08-8 |
| 2-BroMobecloMetasone Dipropionate |
丙酸倍氯米松EP杂质 N |
1204582-47-7 |
| Clindamycin 2,4-Diphosphate |
磷酸克林霉素杂质 I |
1309048-48-3 |
